These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 38847320)

  • 1. The adiponectin-derived peptide ALY688 protects against the development of metabolic dysfunction-associated steatohepatitis.
    Huang Z; Sung HK; Yan X; He S; Jin L; Wang Q; Wu X; Hsu HH; Pignalosa A; Crawford K; Sweeney G; Xu A
    Clin Transl Sci; 2024 Jun; 17(6):e13760. PubMed ID: 38847320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex-based differences in natural killer T cell-mediated protection against diet-induced steatohepatitis in Balb/c mice.
    Cuño-Gómiz C; de Gregorio E; Tutusaus A; Rider P; Andrés-Sánchez N; Colell A; Morales A; Marí M
    Biol Sex Differ; 2023 Nov; 14(1):85. PubMed ID: 37964320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocellular RECK as a Critical Regulator of Metabolic Dysfunction-associated Steatohepatitis Development.
    Dashek RJ; Cunningham RP; Taylor CL; Alessi I; Diaz C; Meers GM; Wheeler AA; Ibdah JA; Parks EJ; Yoshida T; Chandrasekar B; Rector RS
    Cell Mol Gastroenterol Hepatol; 2024; 18(3):101365. PubMed ID: 38797477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardioprotection by the adiponectin receptor agonist ALY688 in a preclinical mouse model of heart failure with reduced ejection fraction (HFrEF).
    Cho S; Dadson K; Sung HK; Ayansola O; Mirzaesmaeili A; Noskovicova N; Zhao Y; Cheung K; Radisic M; Hinz B; Sater AAA; Hsu HH; Lopaschuk GD; Sweeney G
    Biomed Pharmacother; 2024 Feb; 171():116119. PubMed ID: 38181714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic Ablation of STE20-Type Kinase MST4 Does Not Alleviate Diet-Induced MASLD Susceptibility in Mice.
    Caputo M; Andersson E; Xia Y; Hou W; Cansby E; Erikson M; Lind DE; Hallberg B; Amrutkar M; Mahlapuu M
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38397122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel blood-based bioassay to monitor adiponectin signaling.
    Lone AH; Tang J; Pignalosa A; Hsu HH; Abdul-Sater AA; Sweeney G
    Int Immunopharmacol; 2024 May; 132():111890. PubMed ID: 38547772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage ATG16L1 expression suppresses metabolic dysfunction-associated steatohepatitis progression by promoting lipophagy.
    Wang Q; Bu Q; Xu Z; Liang Y; Zhou J; Pan Y; Zhou H; Lu L
    Clin Mol Hepatol; 2024 Jul; 30(3):515-538. PubMed ID: 38726504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patchouli alcohol alleviates metabolic dysfunction-associated steatohepatitis via inhibiting mitochondria-associated endoplasmic reticulum membrane disruption-induced hepatic steatosis and inflammation in rats.
    Xie X; Liao Y; Lin Z; Luo H; Wei G; Huang N; Li Y; Chen J; Su Z; Yu X; Chen L; Liu Y
    Int Immunopharmacol; 2024 Sep; 138():112634. PubMed ID: 38971107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective Effects of Hepatocyte Stress Defenders, Nrf1 and Nrf2, against MASLD Progression.
    Akl MG; Li L; Widenmaier SB
    Int J Mol Sci; 2024 Jul; 25(15):. PubMed ID: 39125617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydrogen-rich water protects against liver injury in nonalcoholic steatohepatitis through HO-1 enhancement via IL-10 and Sirt 1 signaling.
    Li SW; Takahara T; Que W; Fujino M; Guo WZ; Hirano SI; Ye LP; Li XK
    Am J Physiol Gastrointest Liver Physiol; 2021 Apr; 320(4):G450-G463. PubMed ID: 33439102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The slow-release adiponectin analog ALY688-SR modifies early-stage disease development in the D2.
    Bellissimo CA; Gandhi S; Castellani LN; Murugathasan M; Delfinis LJ; Thuhan A; Garibotti MC; Seo Y; Rebalka IA; Hsu HH; Sweeney G; Hawke TJ; Abdul-Sater AA; Perry CGR
    Am J Physiol Cell Physiol; 2024 Apr; 326(4):C1011-C1026. PubMed ID: 38145301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TLR9 is up-regulated in human and murine NASH: pivotal role in inflammatory recruitment and cell survival.
    Mridha AR; Haczeyni F; Yeh MM; Haigh WG; Ioannou GN; Barn V; Ajamieh H; Adams L; Hamdorf JM; Teoh NC; Farrell GC
    Clin Sci (Lond); 2017 Aug; 131(16):2145-2159. PubMed ID: 28687713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Barley sprout extracts reduce hepatic lipid accumulation in ethanol-fed mice by activating hepatic AMP-activated protein kinase.
    Kim YJ; Hwang SH; Jia Y; Seo WD; Lee SJ
    Food Res Int; 2017 Nov; 101():209-217. PubMed ID: 28941686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibiting Interleukin 11 Signaling Reduces Hepatocyte Death and Liver Fibrosis, Inflammation, and Steatosis in Mouse Models of Nonalcoholic Steatohepatitis.
    Widjaja AA; Singh BK; Adami E; Viswanathan S; Dong J; D'Agostino GA; Ng B; Lim WW; Tan J; Paleja BS; Tripathi M; Lim SY; Shekeran SG; Chothani SP; Rabes A; Sombetzki M; Bruinstroop E; Min LP; Sinha RA; Albani S; Yen PM; Schafer S; Cook SA
    Gastroenterology; 2019 Sep; 157(3):777-792.e14. PubMed ID: 31078624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ALY688 elicits adiponectin-mimetic signaling and improves insulin action in skeletal muscle cells.
    Sung HK; Mitchell PL; Gross S; Marette A; Sweeney G
    Am J Physiol Cell Physiol; 2022 Feb; 322(2):C151-C163. PubMed ID: 34910600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adipogenic changes of hepatocytes in a high-fat diet-induced fatty liver mice model and non-alcoholic fatty liver disease patients.
    Pan X; Wang P; Luo J; Wang Z; Song Y; Ye J; Hou X
    Endocrine; 2015 Apr; 48(3):834-47. PubMed ID: 25138963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of hepatic p63 ameliorates steatohepatitis with fibrosis in mice.
    Fondevila MF; Novoa E; Fernandez U; Dorta V; Parracho T; Kreimeyer H; Garcia-Vence M; Chantada-Vazquez MP; Bravo SB; Porteiro B; Cabaleiro A; Koning M; Senra A; Souto Y; Verheij J; Guallar D; Fidalgo M; Meijnikman AS; da Silva Lima N; Dieguez C; Gonzalez-Rellan MJ; Nogueiras R
    Mol Metab; 2024 Jul; 85():101962. PubMed ID: 38815625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NUAK1 promotes metabolic dysfunction-associated steatohepatitis progression by activating Caspase 6-driven pyroptosis and inflammation.
    Sheng M; Huo S; Jia L; Weng Y; Liu W; Lin Y; Yu W
    Hepatol Commun; 2024 Jul; 8(7):. PubMed ID: 38967580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of G protein-coupled receptor kinase 2 (GRK2) in the development of non-alcoholic steatosis and steatohepatitis in mice and humans.
    Cruces-Sande M; Vila-Bedmar R; Arcones AC; González-Rodríguez Á; Rada P; Gutiérrez-de-Juan V; Vargas-Castrillón J; Iruzubieta P; Sánchez-González C; Formentini L; Crespo J; García-Monzón C; Martínez-Chantar ML; Valverde ÁM; Mayor F; Murga C
    Biochim Biophys Acta Mol Basis Dis; 2018 Dec; 1864(12):3655-3667. PubMed ID: 30261289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage p38α promotes nutritional steatohepatitis through M1 polarization.
    Zhang X; Fan L; Wu J; Xu H; Leung WY; Fu K; Wu J; Liu K; Man K; Yang X; Han J; Ren J; Yu J
    J Hepatol; 2019 Jul; 71(1):163-174. PubMed ID: 30914267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.